-
1
-
-
0018354308
-
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature
-
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59: 607-9.
-
(1979)
Circulation
, vol.59
, pp. 607-609
-
-
-
2
-
-
0033887675
-
Chest pain centers: Diagnosis of acute coronary syndromes
-
Storroww AB, Gibler WB. Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med 2000; 35: 449-61.
-
(2000)
Ann Emerg Med
, vol.35
, pp. 449-461
-
-
Storroww, A.B.1
Gibler, W.B.2
-
3
-
-
0031746866
-
C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy
-
Morrrow DA, Rifai N, Antman EA, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiology 1998; 31: 1460-5.
-
(1998)
J Am Coll Cardiology
, vol.31
, pp. 1460-1465
-
-
Morrrow, D.A.1
Rifai, N.2
Antman, E.A.3
Weiner, D.L.4
McCabe, C.H.5
Cannon, C.P.6
Braunwald, E.7
-
4
-
-
0034687438
-
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
-
Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000; 343: 1139-47.
-
(2000)
N Engl J Med
, vol.343
, pp. 1139-1147
-
-
Lindahl, B.1
Toss, H.2
Siegbahn, A.3
Venge, P.4
Wallentin, L.5
-
5
-
-
0034669458
-
Cardiac troponin I for stratification of early outcomes and the efficacy of Enoxaparin in unstable angina: A T/MI-11B substudy
-
Morrrow DA, Antman EA, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, Cannon CP, Braunwald E. Cardiac troponin I for stratification of early outcomes and the efficacy of Enoxaparin in unstable angina: A T/MI-11B substudy. J Am Coll Cardiol 2000; 36: 1812-7.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 1812-1817
-
-
Morrrow, D.A.1
Antman, E.A.2
Tanasijevic, M.3
Rifai, N.4
De Lemos, J.A.5
McCabe, C.H.6
Cannon, C.P.7
Braunwald, E.8
-
6
-
-
0032870734
-
Use of biochemical markers in acute coronary syndromes
-
IFCC Scientific Division, Committee on Stan-dardization of Markers of Cardiac Damage
-
Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Stan-dardization of Markers of Cardiac Damage. Clin Chem Lab Med 1999; 37: 687-93.
-
(1999)
Clin Chem Lab Med
, vol.37
, pp. 687-693
-
-
Panteghini, M.1
Apple, F.S.2
Christenson, R.H.3
Dati, F.4
Mair, J.5
Wu, A.H.6
-
7
-
-
0033003236
-
Proposals from IFCC committee on standardization of markers of cardiac damage (C-SMCD): Recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes
-
Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Proposals from IFCC committee on standardization of markers of cardiac damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. Scan J Clin Lab Invest 1999; 59: 103-12.
-
(1999)
Scan J Clin Lab Invest
, vol.59
, pp. 103-112
-
-
Panteghini, M.1
Apple, F.S.2
Christenson, R.H.3
Dati, F.4
Mair, J.5
Wu, A.H.6
-
8
-
-
0032617282
-
Proposals from IFCC committee on standardization of markers of cardiac damage (C-SMCD): Strategies and concepts on standardization of cardiac marker assays
-
Dati F, Panteghini M, Apple FS, Christenson RH, Mair J, Wu AH. Proposals from IFCC committee on standardization of markers of cardiac damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. Scan J Clin Lab Invest 1999; 59: 113-23.
-
(1999)
Scan J Clin Lab Invest
, vol.59
, pp. 113-123
-
-
Dati, F.1
Panteghini, M.2
Apple, F.S.3
Christenson, R.H.4
Mair, J.5
Wu, A.H.6
-
9
-
-
0033851515
-
Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction
-
The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 959-969
-
-
-
10
-
-
3042736681
-
Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposals
-
Pantegini M. Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposals. eJIFC 2003; 13/2.
-
(2003)
eJIFC
, vol.13
, Issue.2
-
-
Pantegini, M.1
-
11
-
-
0028864049
-
Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room
-
De Winter RJ, Koster RW, Sturk A, Sanders GT. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995; 92: 3401-7.
-
(1995)
Circulation
, vol.92
, pp. 3401-3407
-
-
De Winter, R.J.1
Koster, R.W.2
Sturk, A.3
Sanders, G.T.4
-
12
-
-
0028874946
-
Myoglobin in the early evaluation of acute chest pain
-
Montague C, Kircher T. Myoglobin in the early evaluation of acute chest pain. Am J Clin Pathol 1995; 104: 472-6.
-
(1995)
Am J Clin Pathol
, vol.104
, pp. 472-476
-
-
Montague, C.1
Kircher, T.2
-
13
-
-
0001350164
-
Multicenter evaluation of five methods for myoglobin determination
-
Panteghini M, Altinier S, Dolci A, Pagani F, Pergolini P, Vernocchi A, et al. Multicenter evaluation of five methods for myoglobin determination. Clin Chem 1998; 44: Suppl: A121.
-
(1998)
Clin Chem
, vol.44
, Issue.SUPPL.
-
-
Panteghini, M.1
Altinier, S.2
Dolci, A.3
Pagani, F.4
Pergolini, P.5
Vernocchi, A.6
-
14
-
-
0035949522
-
Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin 1
-
McCord J, Nowak RM, McCullough PA, Foreback C, Borzak S, Tokarski G, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin 1. Circulation 2001; 104: 1483-8.
-
(2001)
Circulation
, vol.104
, pp. 1483-1488
-
-
McCord, J.1
Nowak, R.M.2
McCullough, P.A.3
Foreback, C.4
Borzak, S.5
Tokarski, G.6
-
15
-
-
0027965547
-
Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction
-
Puleo PR, Meyer D, Wathen C, Tawa C, Wheeler S, Hamburg RJ, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331: 561-6.
-
(1994)
N Engl J Med
, vol.331
, pp. 561-566
-
-
Puleo, P.R.1
Meyer, D.2
Wathen, C.3
Tawa, C.4
Wheeler, S.5
Hamburg, R.J.6
-
16
-
-
0029014870
-
Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury
-
Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995; 41: 966-78.
-
(1995)
Clin Chem
, vol.41
, pp. 966-978
-
-
Rabitzsch, G.1
Mair, J.2
Lechleitner, P.3
Noll, F.4
Hofmann, U.5
Krause, E.G.6
-
17
-
-
0032489833
-
Fatty acid-binding protein and the early detection of acute myocardial infarction
-
Glatz JFC, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998; 272: 87-92.
-
(1998)
Clin Chim Acta
, vol.272
, pp. 87-92
-
-
Glatz, J.F.C.1
Van Der Vusse, G.J.2
Simoons, M.L.3
Kragten, J.A.4
Van Dieijen-Visser, M.P.5
Hermens, W.T.6
-
18
-
-
0036092614
-
Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race
-
Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002; 48: 1097-100.
-
(2002)
Clin Chem
, vol.48
, pp. 1097-1100
-
-
Apple, F.S.1
Quist, H.E.2
Otto, A.P.3
Mathews, W.E.4
Murakami, M.M.5
-
19
-
-
0037379905
-
Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction
-
Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003; 49: 581-5.
-
(2003)
Clin Chem
, vol.49
, pp. 581-585
-
-
Bhagavan, N.V.1
Lai, E.M.2
Rios, P.A.3
Yang, J.4
Ortega-Lopez, A.M.5
Shinoda, H.6
-
20
-
-
0029873946
-
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease
-
Lindahl B, Venge P, Wallentin L, for the FRISC Study Subgroup. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-7.
-
(1996)
Circulation
, vol.93
, pp. 1651-1657
-
-
Lindahl, B.1
Venge, P.2
Wallentin, L.3
-
21
-
-
0034806576
-
Mechanism behind the prognostic value of troponin T in unstable coronary artery disease: A FRISC II Substudy
-
Lindahl B, Diderholm E, Lagerquist B, Venge P, Wallentin L, FRISC II investigators. Mechanism behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II Substudy. J Am Coll Cardiol 2001; 38: 979-86.
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 979-986
-
-
Lindahl, B.1
Diderholm, E.2
Lagerquist, B.3
Venge, P.4
Wallentin, L.5
-
22
-
-
0028349701
-
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial (Thrombolysis in Myocardial Ischemia)
-
The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial (Thrombolysis in Myocardial Ischemia). Circulation 1994; 89: 1545-56.
-
(1994)
Circulation
, vol.89
, pp. 1545-1556
-
-
-
23
-
-
18444363329
-
Multicenter evaluation of an automated assay for Troponin 1
-
Uettwiller-Geiger D, Wu A, Apple F, Jevans A, Venge P, Olson M, Darte C, Woodrum D, Roberts S, Chan S Multicenter evaluation of an automated assay for Troponin 1. Clin Chem 2002; 48: 869-76.
-
(2002)
Clin Chem
, vol.48
, pp. 869-876
-
-
Uettwiller-Geiger, D.1
Wu, A.2
Apple, F.3
Jevans, A.4
Venge, P.5
Olson, M.6
Darte, C.7
Woodrum, D.8
Roberts, S.9
Chan, S.10
-
24
-
-
0042474263
-
The increasing impact of laboratory medicine on clinical cardiology
-
Clerico A. The increasing impact of laboratory medicine on clinical cardiology. Clin Chem Lab Med 2003; 41: 871-83.
-
(2003)
Clin Chem Lab Med
, vol.41
, pp. 871-883
-
-
Clerico, A.1
-
25
-
-
0041963115
-
Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European society of Cardiology/American College of Cardiology consensus recommendations
-
Apple F, Quist H, Doyle P, Otto A, Murakami M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49: 1331-6.
-
(2003)
Clin Chem
, vol.49
, pp. 1331-1336
-
-
Apple, F.1
Quist, H.2
Doyle, P.3
Otto, A.4
Murakami, M.5
-
26
-
-
0033037025
-
The lack of standardization of cardiac troponin 1 assay systems
-
Tate JR, Heathcote D, Rayfield J, et al. The lack of standardization of cardiac troponin 1 assay systems. Clin Chim Acta 1999; 284: 141-9.
-
(1999)
Clin Chim Acta
, vol.284
, pp. 141-149
-
-
Tate, J.R.1
Heathcote, D.2
Rayfield, J.3
-
27
-
-
0035885030
-
Recent approaches in standardization of cardiac markers
-
Panteghini M. Recent approaches in standardization of cardiac markers. Clin Chim Acta 2001: 311: 19-25.
-
(2001)
Clin Chim Acta
, vol.311
, pp. 19-25
-
-
Panteghini, M.1
-
28
-
-
0032923760
-
Clinical and analytical standardization of human cardiac troponin 1
-
Apple FS. Clinical and analytical standardization of human cardiac troponin 1. Clin Chem 1999; 45: 18-20.
-
(1999)
Clin Chem
, vol.45
, pp. 18-20
-
-
Apple, F.S.1
-
29
-
-
0032617283
-
New approach to standardization of human cardiac troponin I (cTnl)
-
Katrukha A, Bereznikova A, Pettersson K. New approach to standardization of human cardiac troponin I (cTnl). Scand J Clin Lab Invest 1999; 59(suppl 230): 124-7.
-
(1999)
Scand J Clin Lab Invest
, vol.59
, Issue.SUPPL. 230
, pp. 124-127
-
-
Katrukha, A.1
Bereznikova, A.2
Pettersson, K.3
-
30
-
-
7844241913
-
Degradation of cardiac troponin 1: Implication for reliable immunodetection
-
Katrukha A, Bereznikova A, Filatov V, et al. Degradation of cardiac troponin 1: implication for reliable immunodetection. Clin Chem 1998; 44: 2433-40.
-
(1998)
Clin Chem
, vol.44
, pp. 2433-2440
-
-
Katrukha, A.1
Bereznikova, A.2
Filatov, V.3
-
31
-
-
0034044081
-
Troponin T and I Assays Show Decreased concentrations in heparin plasma compared with serum: Lower recoveries in early than in late phases of myocardial injury
-
Gerhardt W, Nordin G, Herbert A-K, Linaker Burzell B, Isaksson A, Gustavsson E, Haglund S, Muller-Bardorff M, Katus H. Troponin T and I Assays Show Decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000; 46: 817-21.
-
(2000)
Clin Chem
, vol.46
, pp. 817-821
-
-
Gerhardt, W.1
Nordin, G.2
Herbert, A.-K.3
Linaker Burzell, B.4
Isaksson, A.5
Gustavsson, E.6
Haglund, S.7
Muller-Bardorff, M.8
Katus, H.9
-
32
-
-
0035052773
-
Quality specifications for cardiac troponin assays
-
Panteghini M, Gerhardt W, Apple F, Dati F, Ravkilde J, Wu A. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001; 39: 174-8.
-
(2001)
Clin Chem Lab Med
, vol.39
, pp. 174-178
-
-
Panteghini, M.1
Gerhardt, W.2
Apple, F.3
Dati, F.4
Ravkilde, J.5
Wu, A.6
-
33
-
-
0037167699
-
Evidence-based risk stratification to target therapies in acute coronary syndromes
-
Cannon CP. Evidence-based risk stratification to target therapies in acute coronary syndromes. Circulation 2002; 106: 1588-91.
-
(2002)
Circulation
, vol.106
, pp. 1588-1591
-
-
Cannon, C.P.1
-
34
-
-
0036788546
-
ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Unstable Angina)
-
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P. ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Unstable Angina). Circulation 2002; 106: 1893-900.
-
(2002)
Circulation
, vol.106
, pp. 1893-1900
-
-
Braunwald, E.1
Antman, E.M.2
Beasley, J.W.3
Califf, R.M.4
Cheitlin, M.D.5
Hochman, J.S.6
Kereiakes, D.7
Kupersmith, J.8
Levin, T.N.9
Pepine, C.J.10
Schaeffer, J.W.11
Smith, E.E.12
Steward, D.E.13
Theroux, P.14
-
35
-
-
0033609314
-
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
-
Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999; 340: 1623-9.
-
(1999)
N Engl J Med
, vol.340
, pp. 1623-1629
-
-
Hamm, C.W.1
Heeschen, C.2
Goldmann, B.3
-
36
-
-
0033589739
-
Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
-
Heeschen C, Hamm CW, Goldmann B, et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet 1999; 354: 1757-62.
-
(1999)
Lancet
, vol.354
, pp. 1757-1762
-
-
Heeschen, C.1
Hamm, C.W.2
Goldmann, B.3
-
37
-
-
0035912912
-
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: The paragon-B troponin T substudy
-
Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the paragon-B troponin T substudy. Circulation 2001; 103: 2891-6.
-
(2001)
Circulation
, vol.103
, pp. 2891-2896
-
-
Newby, L.K.1
Ohman, E.M.2
Christenson, R.H.3
-
38
-
-
0035161957
-
Elevation in serum troponin 1 predicts the benefit of tirofiban
-
Januzzi JL, Chai CU, Sabatine MS, et al. Elevation in serum troponin 1 predicts the benefit of tirofiban. J Thromb Thrombolysis 2001; 11: 211-5.
-
(2001)
J Thromb Thrombolysis
, vol.11
, pp. 211-215
-
-
Januzzi, J.L.1
Chai, C.U.2
Sabatine, M.S.3
-
39
-
-
0035930101
-
Ability of minor elevations of troponin 1 and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial
-
Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponin 1 and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001; 286: 2405-12.
-
(2001)
JAMA
, vol.286
, pp. 2405-2412
-
-
Morrow, D.A.1
Cannon, C.P.2
Rifai, N.3
-
40
-
-
0035927970
-
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
-
Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-87.
-
(2001)
N Engl J Med
, vol.344
, pp. 1879-1887
-
-
Cannon, C.P.1
Weintraub, W.S.2
Demopoulos, L.A.3
-
41
-
-
0036270810
-
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: The FRISC 11 invasive troponin T electrocardiogram substudy
-
Diderholm E, Andren B, Frostfeldt G, et al. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC 11 invasive troponin T electrocardiogram substudy. Am Heart J 2002; 143: 760-7.
-
(2002)
Am Heart J
, vol.143
, pp. 760-767
-
-
Diderholm, E.1
Andren, B.2
Frostfeldt, G.3
|